FOXP3 and colitis: In 2015, Aubry et al. found that preventive oral administration of MG1363 that secreted thymic stromal lymphopoietin caused a transient increase in the number of CD4+ CD25+ FoxP3+ Treg cells in the mesenteric lymph node and attenuated DSS colitis in mice (45).